A Phase 3 program of CLS-AX in wet AMD (Wet-age-related-macular-degeneration)
Latest Information Update: 19 Apr 2024
At a glance
- Drugs Axitinib (Primary)
- Indications Wet age-related macular degeneration
- Focus Registrational; Therapeutic Use
- 19 Apr 2024 New trial record